by admin | Apr 7, 2020 | News
We have initiated the rapid development of novel medicines forthe treatment of COVID-19. About Us Pulmonomy(a subsidiary of TotalClarity, Inc.) is a biopharma company, targeting a range of life-threatening infections of the lungs. (pulmonomyp.wpengine.com) is focused... by admin | Mar 6, 2020 | News
Lexington, Mass.–Mar. 6, 2020 – Pulmonomy, an inhalation therapeutics-focused subsidiary of TotalClarity, Inc., today announced a collaboration agreement with Cellix Bio for exclusive global rights to develop CLX-159 for the treatment of Invasive Pulmonary...